Subirà M, Domingo A, Santamaría A, Bordes R, Romagosa V, Soler J
Departament d'Hematologia, Hospital de la Santa Creu i San Pau, Barcelona, Spain.
Haematologica. 1997 Sep-Oct;82(5):594-5.
Trephine biopsy (TB) combined with bone marrow aspiration (BMA) is the most common method for evaluating bone marrow (BM) involvement in non-Hodgkin's lymphomas. Nevertheless, the role of TB in high-grade lymphomas remains controversial. We reviewed the results of 42 consecutive BMAs and TBs performed simultaneously in 29 patients with lymphoblastic lymphoma (LL) and small, non-cleaved cell lymphoma (SNCL). In LL, 8M involvement was documented in 35.4% of the cases by BMA and 22.5% of the cases by TB. In SNCL it was documented in 45.4% of the cases by BMA and 36.3% by TB. There were no statistically significant differences (p > 0.05) in the rates of BM involvement found by TB or BMA in the two types of lymphoma, although BMA appeared to be more sensitive than TB. These observations suggest that routine TB may not be necessary in assessing BM involvement in patients with LL and SNCL.
环钻活检(TB)联合骨髓穿刺(BMA)是评估非霍奇金淋巴瘤骨髓(BM)受累情况最常用的方法。然而,TB在高级别淋巴瘤中的作用仍存在争议。我们回顾了对29例淋巴母细胞淋巴瘤(LL)和小无裂细胞淋巴瘤(SNCL)患者同时进行的42次连续BMA和TB的结果。在LL中,BMA检测到35.4%的病例存在骨髓受累,TB检测到22.5%的病例存在骨髓受累。在SNCL中,BMA检测到45.4%的病例存在骨髓受累,TB检测到36.3%的病例存在骨髓受累。两种类型淋巴瘤中,TB或BMA检测到的骨髓受累率无统计学显著差异(p>0.05),尽管BMA似乎比TB更敏感。这些观察结果表明,在评估LL和SNCL患者的骨髓受累情况时,常规TB可能并非必要。